Patent ID: 7109198

Claim:
A method of treating obesity in a mammal comprising administering to a mammal in need of such treatment at least one compound that enhances the activity of norepinephrine and/or dopamine selected from the group consisting of bupropion, atomoxetine, and reboxetine, and at least one weight-loss promoting anticonvulsant wherein said anticonvulsant is of formula (III): wherein R 1 is hydrogen or a halogen atom, R 2 and R 3 are the same or different and are each hydrogen or an alkyl having 1 to 3 carbon atoms, and one of X and Y is a carbon atom and another is a nitrogen atom, provided that the group —CH 2 SO 2 NR 2 R 3 is bonded to the carbon atom of either of X and Y, or an alkali metal salt thereof.